Table 4:
Number | Percent | |
---|---|---|
Interventional Model | ||
Single Group Assignment | 26 | 66.7 |
Parallel Assignment | 11 | 28.2 |
Not Specified | 2 | 5.1 |
Treatment Allocation | ||
Non-randomized | 30 | 76.9 |
Randomized | 9 | 23.1 |
Masking | ||
Open Label | 36 | 92.3 |
Masked | 1 | 2.6 |
Not Specified | 2 | 5.1 |
Main Primary Endpoint | ||
Progression-free Survival | 7 | 17.9 |
Objective Response Rate | 23 | 59.0 |
Clinical Benefit Rate | 2 | 5.1 |
Relapse Rate | 2 | 5.1 |
Safety / Toxicity | 2 | 5.1 |
Efficacy | 3 | 7.7 |